Injective price is showing renewed strength following Coinbase integration, with the exchange’s native INJ support adding fresh momentum to the token’s recovery. The development enhances direct access to the Injective ecosystem while reinforcing the project’s long-term adoption narrative among U.S. investors. As buyers continue defending higher lows, attention is now shifting to whether improving fundamentals can help INJ token clear a major resistance barrier and extend its rally.
Coinbase’s Native Support Expands Injective’s Reach
Injective has officially announced that native INJ is now supported on Coinbase, allowing users to deposit and withdraw the token directly through the Injective blockchain. Unlike wrapped assets or bridge-dependent transfers, native support provides a more seamless experience while reducing friction for users moving assets into the ecosystem.
The integration also represents a meaningful step for Injective’s broader growth strategy. As one of the largest regulated cryptocurrency exchanges in the United States, Coinbase provides exposure to millions of retail and institutional investors. Greater accessibility could translate into stronger ecosystem participation over time, particularly as decentralized finance activity continues to expand across Layer-1 networks. Rather than serving as a short-term listing catalyst, the update reinforces Injective’s long-term infrastructure and adoption story by making the network easier to access and interact with.
Growing Adoption Strengthens Injective’s Fundamental Outlook
Beyond improved accessibility, the Coinbase integration highlights Injective’s continued progress in building a competitive decentralized finance ecosystem.
The network has steadily expanded its infrastructure across decentralized exchanges, real-world asset initiatives, tokenized finance, and AI-powered applications. Easier access through Coinbase may encourage additional liquidity and user participation, both of which are important for sustaining long-term ecosystem growth. While the integration alone does not guarantee higher prices, it strengthens one of the market’s key investment narratives: blockchain networks that continue improving accessibility while expanding utility often attract stronger investor attention during broader market recoveries.
Injective Price Analysis: Bulls Target the $8 Breakout Zone
Injective price continues to build a constructive recovery after successfully defending its long-term demand zone between $3.50 and $4.50. INJ token has been respecting a rising trendline that has supported the recovery throughout recent weeks, while consistently forming higher lows. INJ price has also reclaimed short-term moving averages, reflecting strengthening bullish momentum.
The next major obstacle sits between $7.70 and $8.00, where previous selling pressure created a significant supply zone. A decisive breakout above this region would invalidate the broader lower-high structure that has defined INJ’s correction over recent months and could open the door toward the $10–$12 range. On the downside, failure to maintain the ascending trendline could shift momentum back in favor of sellers, with $4.50 serving as the first key support level, followed by the broader demand zone near $3.50.
Can Coinbase Become the Catalyst for the Next Leg Higher?
Coinbase’s native INJ integration arrives at an important time for Injective. The update improves accessibility, strengthens the project’s long-term adoption narrative, and aligns with a steadily improving technical structure.
Whether Injective Price can extend gains from here will largely depend on buyers reclaiming the $8 resistance zone, where the current recovery faces its biggest technical challenge. A successful breakout would strengthen the bullish case for a broader trend reversal, while failure to clear this level could keep INJ consolidating before its next directional move.